Pandurangan Vijayanand

La Jolla Institute for Immunology

La Jolla, CA

United States

SCHOLARLY PAPERS

2

DOWNLOADS

96

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells

Number of pages: 39 Posted: 07 Jul 2020
La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, University of Southampton - Faculty of Medicine, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, University Hospitals NHS Foundation Trust - Southampton Specialist Virology Center, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Immunology and La Jolla Institute for Immunology
Downloads 58 (485,660)
Citation 10

Abstract:

Loading...

2.

T FR Cells Inhibit Anti-Tumor Immunity and are Responsive to Immune Checkpoint Blockade

Number of pages: 52 Posted: 13 May 2020
La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of Southampton, University of Southampton, Southampton University Hospitals NHS Foundation Trust, Southampton University Hospitals NHS Foundation Trust, University of Nottingham, University of Southampton, University of Southampton, University of Southampton - Department of Clinical and Experimental Sciences, University of Southampton, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla Institute for Immunology and La Jolla Institute for Immunology
Downloads 38 (576,324)
Citation 1

Abstract:

Loading...

TFR cells, TREG cells, single-cell RNA-seq, Immune checkpoint blockade (ICB), CTLA-4, PD-1, sequential therapy, NSCLC, HNSCC, Melanoma